Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Smith

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
American Journal of Medical Genetics. Part A|July 22, 2004
Germline mosaicism resulting in the transmission of severe hemophilia B from a grandfather with a mild deficiencyJacqueline A Cutler, Michael J Mitchell, Mark P Smith, et al.
Thrombosis and Haemostasis|October 7, 2004
Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy. A pharmacokinetic studyLucy A Norris, John Bonnar, Mark P Smith, et al.
Journal of Shoulder and Elbow Surgery|April 21, 2025
Internal joint stabilizer vs. stand-alone ligament repair in treatment of traumatic elbow instability: an age-matched analysisMark P Smith, Mark T Dillon, Ryan J Kozlowski, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Tinzaparin sodium for thrombosis treatment and prevention during pregnancyMark P Smith, Lucy A Norris, Philip J Steer, et al.
Blood Cells, Molecules & Diseases|January 8, 2011
Genotyping the factor VIII intron 22 inversion locus using fluorescent in situ hybridizationCampbell R Sheen, Margaret A McDonald, Peter M George, et al.
British Journal of Haematology|March 5, 2003
A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluationChristopher A Ludlam, Mark P Smith, Massimo Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2020
Impact of treatment regimen with moroctocog alfa (AF-CC) on bleeding rates in paediatric patients with severe haemophilia AMark P Smith, Jeremy Rupon, Yasser Wali, et al.
The Medical Journal of Australia|January 22, 2008
Written advice can provide a safe and acceptable alternative to new patient assessment for selected referrals to haematologistsPeter S Ganly, Helen Keeman, Ruth L Spearing, et al.
British Journal of Haematology|October 6, 2007
Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysisEmmanuel J Favaloro, David Patterson, Anna Denholm, et al.
Blood|March 1, 2003
Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorderYatin M Patel, Kirti Patel, Salman Rahman, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
American Journal of Medical Genetics. Part A|July 22, 2004
Germline mosaicism resulting in the transmission of severe hemophilia B from a grandfather with a mild deficiencyJacqueline A Cutler, Michael J Mitchell, Mark P Smith, et al.
Thrombosis and Haemostasis|October 7, 2004
Low molecular weight heparin (tinzaparin) therapy for moderate risk thromboprophylaxis during pregnancy. A pharmacokinetic studyLucy A Norris, John Bonnar, Mark P Smith, et al.
Journal of Shoulder and Elbow Surgery|April 21, 2025
Internal joint stabilizer vs. stand-alone ligament repair in treatment of traumatic elbow instability: an age-matched analysisMark P Smith, Mark T Dillon, Ryan J Kozlowski, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Tinzaparin sodium for thrombosis treatment and prevention during pregnancyMark P Smith, Lucy A Norris, Philip J Steer, et al.
Blood Cells, Molecules & Diseases|January 8, 2011
Genotyping the factor VIII intron 22 inversion locus using fluorescent in situ hybridizationCampbell R Sheen, Margaret A McDonald, Peter M George, et al.
British Journal of Haematology|March 5, 2003
A prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluationChristopher A Ludlam, Mark P Smith, Massimo Morfini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2020
Impact of treatment regimen with moroctocog alfa (AF-CC) on bleeding rates in paediatric patients with severe haemophilia AMark P Smith, Jeremy Rupon, Yasser Wali, et al.
The Medical Journal of Australia|January 22, 2008
Written advice can provide a safe and acceptable alternative to new patient assessment for selected referrals to haematologistsPeter S Ganly, Helen Keeman, Ruth L Spearing, et al.
British Journal of Haematology|October 6, 2007
Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysisEmmanuel J Favaloro, David Patterson, Anna Denholm, et al.
Blood|March 1, 2003
Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorderYatin M Patel, Kirti Patel, Salman Rahman, et al.
Pageof 3